CompletedPHASE1, PHASE2NCT01290484
A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations
Studying Isolated rare lymphatic malformation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Stanford University
- Principal Investigator
- Alfred T Lane, MDStanford University
- Intervention
- Sildenafil(drug)
- Enrollment
- 7 enrolled
- Eligibility
- 10 years · All sexes
- Timeline
- 2010 – 2013
Study locations (1)
- Stanford University School of Medicine, Stanford, California, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01290484 on ClinicalTrials.gov